1 |
Von Bültzingslowen I, Sollecito TP, Fox PC et al. Salivary dysfunction associated with systemic diseases: systematic review and clinical management recommendations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103(Suppl 1):S57.e1-S57.e15
DOI
ScienceOn
|
2 |
Vissink A, 's-Gravenmade EJ, Panders AK et al. A clinical comparison between commercially available mucin- and CMC-containing saliva substitutes. Int J Oral Surg 1983;12:232-238
DOI
PUBMED
|
3 |
Duxbury AJ, Thakker NS, Wastell DG. A double-blind cross-over trial of a mucin-containing artificial saliva. Br Dent J 1989;166:115-120
DOI
ScienceOn
|
4 |
Johansson G, Andersson G, Attström R, Glantz PO, Larsson K. The effect of Salinum on the symptoms of dry mouth: a pilot study. Gerodontology 1994;11: 46-49
DOI
PUBMED
|
5 |
Lee SG, Jeon EH, Kho HS. Influences of animal mucins on peroxidase activity in solution and on the surface of hydroxyapatite. Korean J Oral Med 2008;33: 229-240
|
6 |
Bennick A, Cannon M. Quantitative study of the interaction of salivary acidic proline-rich proteins with hydroxyapatite. Caries Res 1978;12:159-169
DOI
ScienceOn
|
7 |
Jolles P, Jolles J. What's new in lysozyme research? Always a model system, today as yesterday. Mol Cell Biochem 1984;63:165-189
DOI
PUBMED
|
8 |
O'Brien PJ. Peroxidases. Chem Biol Interact 2000;129:113-139
DOI
ScienceOn
|
9 |
Scannapieco FA, Torres G, Levine MJ. Salivary -amylase: role in dental plaque and caries formation. Crit Rev Oral Biol Med 1993;4:301-307
DOI
|
10 |
Iontcheva I, Oppenheim FG, Troxler RF. Human salivary mucin MG1 selectively forms heterotypic complexes with amylase, proline-rich proteins, statherin, and histatins. J Dent Res 1997;76:734-743
DOI
ScienceOn
|
11 |
Cohen RE, Levine MJ. Salivary glycoproteins. In: Tenovuo JO, ed. Human Saliva: Clinical Chemistry and Microbiology. Vol I. Boca Raton, 1989, CRC Press Inc., pp. 101-130
|
12 |
Regelink G, Vissink A, Reintsema H, Nauta JM. Efficacy of a synthetic polymer saliva substitute in reducing oral complaints of patients suffering from irradiation-induced xerostomia. Quintessence Int 1998;29:383-388
PUBMED
|
13 |
Olsson H, Axell T. Objective and subjective efficacy of saliva substitutes containing mucin and carboxymethylcellulose. Scand J Dent Res 1991;99:316-319
DOI
PUBMED
|
14 |
Fox PC. Systemic therapy of salivary gland hypofunction. J Dent Res 1987;66:689-692
DOI
PUBMED
|
15 |
Ihalin R, Loimaranta V, Tenovuo J. Origin, structure, and biological activities of peroxidases in human saliva. Arch Biochem Biophys 2006;445:261-268
DOI
ScienceOn
|
16 |
Levine MJ, Aguirre A, Hatton MN, Tabak LA. Artificial saliva: Present and future. J Dent Res 1987;66:693-698
DOI
PUBMED
|
17 |
Park MS, Chung JW, Kim YK, Chung SC, Kho HS. Viscosity and wettability of animal mucin solutions and human saliva. Oral Dis 2007;13:181-186
DOI
ScienceOn
|
18 |
Ihalin R, Loimaranta V, Tenovuo J. Origin, structure, and biological activities of peroxidases in human saliva. Arch Biochem Biophys 2006;445:261-268
DOI
ScienceOn
|
19 |
Thomson WM, Lawrence HP, Broadbent JM, Poulton R. The impact of xerostomia on oral-health-related quality of life among younger adults. Health Qual Life Outcomes 2006;4:86
DOI
ScienceOn
|
20 |
Vissink A, Schaub RMH, Van Rijn LJ, s-Gravenmade EJ, Panders AK, Vermey A. The efficacy of mucincontaining artificial saliva in alleviating symptoms of xerostomia. Gerodontology 1987;6:95-101
DOI
PUBMED
|
21 |
Laible NJ, Germaine GR. Bactericidal activity of human lysozyme, muramidase-inactive lysozyme, and cationic polypeptides against Streptococcus sanguis and Streptococcus faecalis: inhibition by chitin oligosaccharides. Infect Immun 1985;48:720-728
PUBMED
|
22 |
Hatton MN, Levine MJ, Margarone JE, Aguirre A. Lubrication and viscosity features of human saliva and commercially available saliva substitutes. J Oral Maxillofac Surg 1987;45:496-499
DOI
|
23 |
Fox PC, Busch K, Baum BJ. Subjective reports of xerostomia and objective measures of salivary gland performance. J Am Dent Assoc 1987;115:581-584
DOI
|
24 |
Soares RV, Siqueira CC, Bruno LS, Oppenheim FG, Offner GD, Troxler RF. MG2 and lactoferrin form a heterotypic complex in salivary secretions. J Dent Res 2003;82:471-475
DOI
ScienceOn
|
25 |
Ikebe K, Matsida K, Morri K et al. Impact of dry mouth and hyposalivation on oral health-related quality of life of elderly Japanese. Oral Surg Oral Med
Oral Pathol Oral Radiol Endod 2007;103:216-222
DOI
ScienceOn
|
26 |
Fox PC. Salivary enhancement therapies. Caries Res 2004;38:241-246
DOI
PUBMED
ScienceOn
|
27 |
Glantz P, Friberg S. Time-dependent rheological behaviour of saliva. Odontol Revy 1970;21:279-285
PUBMED
|
28 |
Vissink A, Waterman HA, 's-Gravenmade EJ, Panders AK, Vermey A. Rheological properties of saliva substitutes containing mucin, carboxymethylcellulose or polyethylenoxide. J Oral Pathol 1984;13:22-28
DOI
PUBMED
|
29 |
Tenovuo J. Clinical applications of antimicrobial host proteins lactoperoxidase, lysozyme and lactoferrin in xerostomia: efficacy and safety. Oral Dis 2002;8:23-29
DOI
PUBMED
ScienceOn
|
30 |
Suh KI, Lee JY, Chung JW, Kim YK, Kho HS. Relationship between salivary flow rate and clinical symptoms and behaviors in patients with dry mouth. J Oral Rehabil 2007;34:739-744
DOI
ScienceOn
|
31 |
Park WK, Chung JW, Kim YK, Chung SC, Kho HS. Influences of animal mucins on lysozyme activity in solution and on hydroxyapatite surfaces. Arch Oral Biol 2006;51:861-869
DOI
ScienceOn
|
32 |
Valdez IH, Fox PC. Diagnosis and management of salivary dysfunction. Crit Rev Oral Biol Med 1993;4: 271-277
DOI
|
33 |
Porter SR, Scully C, Hegarty AM. An update of the etiology and management of xerostomia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;97:28-46
DOI
ScienceOn
|
34 |
Scannapieco FA, Bergy EJ, Reddy MS, Levine MJ. Characterization of the salivary -amylase binding to Streptococcus sanguis. Infect Immun 1989;57: 2853-2863
PUBMED
|
35 |
Waterman HA, Blom C, Holterman HJ,'s-Gravenmade EJ, Mellena J. Rheological properties of human saliva. Arch Oral Biol 1988;33:589-596
DOI
ScienceOn
|
36 |
Mandel ID. The functions of saliva. J Dent Res 1987;66:436-441
DOI
PUBMED
ScienceOn
|
37 |
Blixt-Johansen G, Ek AC, Ganowiak W et al. Improvement of oral mucosa with mucin containing artificial saliva in geriatric patients. Arch Gerontol Geriatr 1992;14:193-201
DOI
ScienceOn
|
38 |
Ibrahim HR, Matsuzaki T, Aoki T. Genetic evidence that antibacterial activity of lysozyme is independent of its catalytic function. FEBS Letters 2001;506:27-32
DOI
ScienceOn
|
39 |
Levine MJ. Development of artificial salivas. Crit Rev Oral Biol Med 1993;4:279-286
DOI
|
40 |
Vissink A, De Jong HP, Busscher HJ, Arends J,'s-Gravenmade EJ. Wetting properties of human saliva and saliva substitutes. J Dent Res 1986;65: 1121-1124
DOI
PUBMED
ScienceOn
|
41 |
Mansson-Rahemtulla B, Baldone DC, Pruitt KM, Rahemtulla F. Specific assays for peroxidases in human saliva. Arch Oral Biol 1986;31:661-668
DOI
ScienceOn
|
42 |
Sreebny LM, Valdini A. Xerostomia part I: relationship to other oral symptoms and salivary gland performance. Oral Surg Oral Med Oral Pathol 1988;66:451-458
DOI
ScienceOn
|
43 |
Epstein JB, Emerton S, Le ND, Stevenson-Moore P. A double-blind crossover trial of Oral Balance gel and Biotene toothpaste versus placebo in patients with xerostomia following radiation therapy. Oral Oncol 1999;35:132-137
DOI
ScienceOn
|
44 |
Grossowicz N, Ariel M. Methods for determination of lysozyme activity. Methods Biochem Anal 1983; 29:435-446
DOI
PUBMED
|